Copenhagen Oe

• Phase 1 Trial of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of RP-1664 in Participants with Advanced … Ended
  2024-511259-16-00 1 2025-02-24 Advanced Solid Tumors
• A first-in-human trial of safety and efficacy of GEN1078 in participants with solid tumors. Ended
  2024-515752-21-00 7 2025-01-29 Malignant solid tumors
• Ephedrine 0.15 mg/kg for reducing onset time of rocuronium 0.6 mg/kg in elderly patients. Ended
  2024-517933-42-00 6 2025-01-13 Elective surgery
• Open-Label Extension of EryDex in A-T (OLE NEAT) Ended
  2024-513618-37-00 5 2024-12-23 Ataxia Telangiectasia (A-T)
• ARETHA: cARdiomems vEriciguaT Heart fAilure (A double-blind randomized placebo-controlled trial of vericiguat in heart failure patients with … Ended
  2024-514111-10-00 6 2024-12-06 Heart failure with reduced ejection fraction (HFrEF)
• Is dermal measles-mumps-rubella-vaccine administration better than regular injection? Ended
  2023-503845-79-01 4 2024-11-24 Measles, mumps, and rubella
• Safety Trial, DSC vs. BAT in SR acute GvHD Ended
  2024-511768-97-01 4 2024-11-20 Graft vs Host Disease
• A Phase 1/2a Study Evaluating the Effects of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosi … Ended
  2023-504964-41-00 7 2024-11-06 Idiopathic pulmonary fibrosis
• A Phase 1b study of inhaled RCT1100 in Adults with Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mu … Ended
  2023-510521-14-00 3 2024-10-18 Adults with Primary Ciliary Dyskinesia
• Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dos … Ended
  2023-506000-50-00 4 2024-09-26 Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-H
• A trial to learn how AZD4604 acts in the body and how safe it is in adults with asthma Ended
  2023-510291-32-00 4 2024-09-26 Asthma
• A study of aficamten (CK-3773274) in adults with symptomatic non-obstructive hypertrophic cardiomyopathy (ACACIA) Ended
  2023-505797-15-00 5 2024-09-13 SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
• A Phase 1/2 Study of AMG 193 in Combination with IDE397 in Subjects with Advanced MTAP-null Solid Tumors Ended
  2023-504364-42-00 9 2024-09-12 In Part 1, subjects with advanced MTAP-null solid tumors and, in Part
• A safety study of PF-08046044/SGN-35C in adults with advanced cancers Ended
  2023-505813-26-00 1 2024-09-12 Lymphoma, Large B-Cell, Diffuse
• A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended
  2023-508395-11-00 4 2024-09-10 idiopathic pulmonary fibrosis
• Safety and Efficacy of NMD670 in Adult Patients with Type 1 and Type 2 Charcot-Marie-Tooth Disease Ended
  2023-507892-23-00 4 2024-08-30 Charcot-Marie-Tooth Disease Type 1 and Type 2
• A blinded randomized study of two types of reversal agents (neostigmine/glycopyrrolate 50 mikrogram/kg or sugammadex 2 mg/kg) for reversal o … Ended
  2023-504230-21-00 6 2024-08-12 Anaesthesia to laparoscopic robotassisted surgery
• Evaluation of ELX/TEZ/IVA in Cystic Fibrosis Subjects 12 to Less Than 24 Months of Age Ended
  2023-503230-49-00 5 2024-07-16 Cystic Fibrosis
• An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian … Ended
  2023-508149-42-00 3 2024-07-16 Infertility in women undergoing assisted reproductive technologies (AR
• Comparison of cocaine, lidocaine/xylometazoline and saline for intranasal analgesia - A blinded triple crossover study Ended
  2023-506644-17-01 5 2024-07-01 Nasotracheal intubation
• Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction Ended
  2023-506210-40-00 5 2024-06-28 Heart Failure due to Systemic Left Ventricular Systolic Dysfunction
• A safety study of PF-08046045/SGN-35T in adults with advanced cancers Ended
  2022-502390-41-00 1 2024-06-20 Enteropathy-Associated T-Cell Lymphoma
• An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation Ended
  2023-507630-25-00 3 2024-06-14 Infertility in women undergoing assisted reproductive technologies (AR
• Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or … Ended
  2023-508884-59-00 5 2024-06-03 Hemophilia A or Hemophilia B

Showing 553–576 of 671 trials